These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9778230)

  • 1. Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.
    Marie I; Levesque H; Ducrotté P; Denis P; Benichou J; Hellot MF; Cailleux N; Le Loët X; Joly P; Lauret P; Courtois H
    Arthritis Rheum; 1998 Oct; 41(10):1874-83. PubMed ID: 9778230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up.
    Marie I; Ducrotté P; Denis P; Hellot MF; Levesque H
    Rheumatology (Oxford); 2007 Jan; 46(1):150-3. PubMed ID: 16782730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric involvement in systemic sclerosis: a prospective study.
    Marie I; Levesque H; Ducrotté P; Denis P; Hellot MF; Benichou J; Cailleux N; Courtois H
    Am J Gastroenterol; 2001 Jan; 96(1):77-83. PubMed ID: 11197291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
    Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis.
    Lock G; Pfeifer M; Straub RH; Zeuner M; Lang B; Schölmerich J; Holstege A
    Am J Gastroenterol; 1998 Mar; 93(3):341-5. PubMed ID: 9517636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal dysmotility in scleroderma: a prospective study of 183 cases.
    Lahcene M; Oumnia N; Matougui N; Boudjella M; Tebaibia A; Touchene B
    Gastroenterol Clin Biol; 2009; 33(6-7):466-9. PubMed ID: 19540687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis.
    Lock G; Straub RH; Zeuner M; Antoniou E; Holstege A; Schölmerich J; Lang B
    J Rheumatol; 1998 Jul; 25(7):1330-5. PubMed ID: 9676765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy.
    Marie I; Ducrotte P; Denis P; Hellot MF; Levesque H
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1593-601. PubMed ID: 17206947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdigestive motor activity in patients with systemic sclerosis.
    Rees WD; Leigh RJ; Christofides ND; Bloom SR; Turnberg LA
    Gastroenterology; 1982 Sep; 83(3):575-80. PubMed ID: 6124475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy.
    Rosztóczy A; Róka R; Várkonyi TT; Lengyel C; Izbéki F; Lonovics J; Wittmann T
    Z Gastroenterol; 2004 Nov; 42(11):1295-300. PubMed ID: 15558439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.
    Weston S; Thumshirn M; Wiste J; Camilleri M
    Am J Gastroenterol; 1998 Jul; 93(7):1085-9. PubMed ID: 9672335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Esophageal motility abnormalities in systemic sclerosis: frequency and predictive factors].
    Karoui S; Serghini M; Ghouma M; Zouiten L; Matri S; Ben Ghorbel I; Kallel L; Boubaker J; Houmane H; Filali A
    Tunis Med; 2009 Aug; 87(8):511-5. PubMed ID: 20180353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients.
    Gemignani L; Savarino V; Ghio M; Parodi A; Zentilin P; de Bortoli N; Negrini S; Furnari M; Dulbecco P; Giambruno E; Savarino E
    Semin Arthritis Rheum; 2013 Apr; 42(5):522-9. PubMed ID: 23352249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel motility in functional chronic constipation.
    Seidl H; Gundling F; Pehl C; Pfeiffer A; Schepp W; Schmidt T
    Neurogastroenterol Motil; 2009 Dec; 21(12):1278-e122. PubMed ID: 19614887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC; Hasler WL; Owyang C
    N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship among VIP plasma levels, esophageal dysfunction, and microcirculation in systemic sclerosis].
    Danese C; Caiola S; Lucia P; Cedrone L; Colotto M; Arceri D; Angrisani L
    Minerva Med; 2000 Sep; 91(9):185-9. PubMed ID: 11220202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal involvement in mixed connective tissue disease.
    Doria A; Bonavina L; Anselmino M; Ruffatti A; Favaretto M; Gambari P; Peracchia A; Todesco S
    J Rheumatol; 1991 May; 18(5):685-90. PubMed ID: 1865414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal manometry in patients with systemic sclerosis.
    Sjölund K; Bartosik I; Lindberg G; Scheja A; Wildt M; Akesson A
    Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1205-12. PubMed ID: 16215433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of intestinal manometry in gastrointestinal pathology].
    Madrid AM; Quera R; Defilippi C
    Rev Med Chil; 1999 Oct; 127(10):1176-82. PubMed ID: 10835733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.